Contrasting Heyu Biological Technology (OTCMKTS:HYBT) and Electromed (NYSE:ELMD)

Heyu Biological Technology (OTCMKTS:HYBT) and Electromed (NYSE:ELMD) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Volatility & Risk

Heyu Biological Technology has a beta of -17.74, indicating that its share price is 1,874% less volatile than the S&P 500. Comparatively, Electromed has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500.

Insider & Institutional Ownership

40.8% of Electromed shares are owned by institutional investors. 89.2% of Heyu Biological Technology shares are owned by company insiders. Comparatively, 14.0% of Electromed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for Heyu Biological Technology and Electromed, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heyu Biological Technology	0	0	0	0	0.00
Electromed	0	0	0	1	4.00

Electromed has a consensus price target of $38.00, indicating a potential upside of 108.33%. Given Electromed’s stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than Heyu Biological Technology.

Valuation & Earnings

This table compares Heyu Biological Technology and Electromed”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heyu Biological Technology	$80,000.00	176.81	-$270,000.00	N/A	N/A
Electromed	$61.44 million	2.49	$5.15 million	$0.79	23.09

Electromed has higher revenue and earnings than Heyu Biological Technology.

Profitability

This table compares Heyu Biological Technology and Electromed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heyu Biological Technology	-453.55%	-6.43%	-4.43%
Electromed	11.34%	15.71%	13.37%

Summary

Electromed beats Heyu Biological Technology on 10 of the 12 factors compared between the two stocks.

About Heyu Biological Technology

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

About Electromed

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.